The patients treated with metformin plus sulfonylurea (S+M group) showed a significantly higher prevalence of vitamin B12 deficiency compared with those treated with metformin plus insulin (I+M group) for the same time period. The gene discussed is INS; the disease is vitamin B12 deficiency.